Metraipolis › archive › dc_2c4b43efa3db
Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42433747
- DOI
- 10.1097/ms9.0000000000005050
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T13:46:51.604Z
- SHA-256 of the archived text
8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d- Stable URL of this page
https://metraipolis.com/documento/dc_2c4b43efa3db
How to cite
Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747 — Europe PMC (en), https://europepmc.org/article/MED/42433747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c4b43efa3db (Metraipolis archive dc_2c4b43efa3db, sha256 8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d)
BibTeX
@misc{dc2c4b43efa3db,
title = {Efficacy and safety of rivaroxaban plus aspirin compared with aspirin alone in patients with peripheral arterial disease: a systematic review and meta-analysis — Europe PMC PMID:42433747},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42433747},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c4b43efa3db; sha256 8ff46cd6bf499e7df770489892af700d5875b7e8ffb79564d0a2707881394d7d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42433747. Agents can read the archived copy with the MCP tool read_document.